Science behind vaccines: Australia’s capacity for large scale fermentation production of biologics

Presented by the VIC Division. This event explores the scope of Australia’s capacity for large scale fermentation production of biologics. With the COVID-19 pandemic inescapably at the forefront of everyone’s minds, much hope is resting on the Australian rollout of an effective vaccine (or two or more). This is a timely opportunity to hear from three leading Australian scientists at the forefront of researching, developing and manufacturing vaccines, from the R&D process, through rigorous clinical trials to manufacture of a COVID-19 vaccine. Thursday 11 March 2021 | 5:30pm-7:00pm AEDT Graduate House Melbourne, 220 Leicester St, Carlton VIC 3053 --------- FACILITATOR Professor Bronwyn Fox FTSE Deputy Vice-Chancellor (Research and Enterprise) Swinburne University --------- SPEAKERS Professor Bruce Thompson Dean, Health Science, Swinburne University Dr Nicole van der Weeden Executive Director and CEO, Hexima Limited Professor Susie Nilsson Biology Group Leader, CSIRO Biomedical Manufacturing Program Dr Anthony Stowers Senior VP, Recombinant & Gene Therapy Product Development, CSL